Feedback

Pfizer asks EU to greenlight its vaccine for children aged 5 - 11

Source : 112 Ukraine

Pfizer and BioNTech submitted data to the European Medicines Agency, including late-stage results from a study testing their Covid-19 vaccine in more than 2,200 children aged 6 months to 11 years.
13:29, 16 October 2021

American biotech company Pfizer
Sky News

Pharmaceutical company Pfizer and biotechnology company BioNTech have requested to have their coronavirus vaccine licensed for children aged 5 -11 across the European Union. This is stated in the joint press release of the companies. 

If EU regulators agree, it would be the first opportunity for younger children in Europe to get immunized against Covid-19.

Pfizer and BioNTech submitted data to the European Medicines Agency, including late-stage results from a study testing their Covid-19 vaccine in more than 2,200 children aged 6 months to 11 years. The children received a lower dose than what's normally given to adults.

Related: WHO again opposes vaccination requirements as condition of entry into countries

The companies said in a statement that the results showed a “strong immune response” in the children and that the vaccine was also found to be safe. There are currently no Covid-19 vaccines licensed for use in children younger than 12 in Europe or North America; the ones made by Pfizer-BioNTech and Moderna are authorized for children 12 and older in the European Union.

Earlier this month, Pfizer and BioNTech asked the U.S. Food and Drug Administration to greenlight their vaccine for children aged 5 - 11.

Related: Unvaccinated citizens not to be allowed on trains, - Ukrzaliznytsia

Topics:
Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

Comments
see more